Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 156

Results For "therapeutic"

1717 News Found

Dr Reddy’s launch valsartan tablets in the US market
Drug Approval | December 09, 2021

Dr Reddy’s launch valsartan tablets in the US market

Dr. Reddy's valsartan tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90


Roche develops tests to identify Omicron variant
Medical Device | December 06, 2021

Roche develops tests to identify Omicron variant

Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions


Lilly's bamlanivimab with etesevimab authorized for emergency use in Covid-19 patients under 12
Drug Approval | December 06, 2021

Lilly's bamlanivimab with etesevimab authorized for emergency use in Covid-19 patients under 12

Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients


Morpen gets U.S. FDA approval for Fexofinadine
Drug Approval | December 05, 2021

Morpen gets U.S. FDA approval for Fexofinadine

Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever


Apollo Health Ventures closes US $ 180 million fund
Startup | December 05, 2021

Apollo Health Ventures closes US $ 180 million fund

The fund aims at investing in companies that extends human healthspan


Novartis showcases its attractive growth pipeline
News | December 03, 2021

Novartis showcases its attractive growth pipeline

Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint


Sanofi to acquire Origimm Biotechnology to treat acne with vaccine
News | December 02, 2021

Sanofi to acquire Origimm Biotechnology to treat acne with vaccine

Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide


Thermo Fisher Scientific’s new CRISPR Genome editing protein
Biotech | November 30, 2021

Thermo Fisher Scientific’s new CRISPR Genome editing protein

Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications


Baidu and Sanofi to collaborate for next-gen mRNA therapy and vaccines
Biotech | November 26, 2021

Baidu and Sanofi to collaborate for next-gen mRNA therapy and vaccines

This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs


Aadi Bioscience secures U.S FDA approval of its first product Fyarro
Drug Approval | November 26, 2021

Aadi Bioscience secures U.S FDA approval of its first product Fyarro

Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults